News

Prime-A-Pump allows healthcare professionals to configure the safety limits within their pump drug library software, thereby preventing serious medication administration errors. The tool utilises an evidence- and experience-based

A third, undisclosed Janssen program was also terminated. Each party has regained all commercial rights for its respective drug discovery programs. The OX-CLI and OX-ESI programs, focusing on

The trial is the second of the company’s two phase III studies that comprise its global registrational program for Feraheme (ferumoxytol). The two phase III studies include one

The MaxCyte STX can transfect from 5E5 to 1E10 cells with comparable results from small bench scale through screening and cGMP manufacturing. MaxCyte STX demonstrated the potential to

The net loss was significantly reduced to $3.8m for the second quarter, compared to a net loss of $12.4m for the second quarter in fiscal 2011. The net

Rock Creek is reporting initial results from Phase 2 of the RCP-006 study titled ‘A Single Center, Single-Blind, Randomized, Crossover Pilot Study to Evaluate the Safety and Efficacy

Lavela WS 1265, the clinically validated oil, has been shown to promote relaxation and calm nervousness with safety and efficacy, as demonstrated in controlled trials. In addition, the

FilmArray respiratory panel is a Multiplex PCR assay currently FDA cleared for 15 respiratory pathogens. The additional five pathogens for which the company filed are Bordetella pertussis, Chlamydophila

Erivedge capsule, taken orally once-a-day, is the first FDA-approved medicine for people with advanced forms of the most common skin cancer. The approval is based on results from